In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on EDAP TMS (EDAP – Research Report), with a price target of $10.00. The company’s shares closed yesterday at $5.76.
According to TipRanks, Takkinen is a 4-star analyst with an average return of 11.5% and a 43.48% success rate. Takkinen covers the Healthcare sector, focusing on stocks such as Artivion, Inspire Medical Systems, and Silk Road Medical.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for EDAP TMS with a $10.00 average price target.
See today’s best-performing stocks on TipRanks >>
EDAP market cap is currently $212.7M and has a P/E ratio of -9.32.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
EDAP TMS (EDAP) Company Description:
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses in the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.
Read More on EDAP:
- EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
- EDAP TMS management to meet with Lake Street
- EDAP TMS announces completion of enrollment in Phase 3 study of HIFU therapy
- EDAP TMS announces preliminary Q4 Focal One system sales, placements
- EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
